Art Schuermans

What does the circulating proteome teach us about common heart diseases? Thrilled to share our analysis identifying new biomarkers, drug targets, and prediction models for these conditions. Co-led by @APournamdari, with @mchonig and @pnatarajanmd nature.com/articles/s4416… (1/x)

Pleased to share our @JAMACardio study developing an improved polygenic score for PAD! Very grateful for mentorship from @AniruddhPatelMD and @pnatarajanmd on this; and to work alongside @Yunfeng_Ruan and the rest of our group! 🧬🧬 @broadinstitute @MGHHeartHealth @MGHSurgery

An absolute risk generalizable risk calculator is challenging. Led by @somijemmacho, evaluating AHA PREVENT across 4 academic health systems, we found similar discrimination but variable calibration. A universal absolute risk threshold may not suitably guide.…

[1/10] At last, @MassGenBrigham x @MountSinaiNYC x @PennMedicine x @VUMChealth collaboration on external validation of the @AHAScience's PREVENT is now out in @JACCJournals! sciencedirect.com/science/articl…

🔥Hot off the press in @JACCJournals: In pediatric HCM, myocardial work (MW) declines over time and is linked to adverse outcomes. MW adds prognostic insight, but doesn’t outperform GLS (yet). 🔗: doi.org/10.1016/j.jaca… Thanks to all co-authors! 🙏 #CardioTwitter #HCM

In a multi-center Danish cardiovascular screening study primarily of men, JAK2 V617F was enriched among those with thoracic aortic aneurysm (2.7-fold for larger clones) ahajournals.org/doi/full/10.11… @CircAHA (consistent with our @uk_biobank study for incident thoracic aortic aneurysm…

Very nice work from A. Pandey, D. Tong, S. Chung @utswnews showing an enrichment of TET2 clonal hematopoiesis among individuals with HFpEF with recapitulation in a murine model supporting causality ahajournals.org/doi/abs/10.116… @CircAHA

So grateful to have the opportunity to present our work! Thank you to @mchonig for the incredible mentorship and support!

Huge congrats to @amandajowell @mghmedres for receiving a top resident abstract award for her analysis of female-specific CVD risk factors in severe hypercholesterolemia 🏆 @MGHHeartHealth @mghcvrc @MGHWomenHeart

CALL FOR SUBMISSIONS: JAHA Spotlight on Cardiovascular Disease in Rheumatology and Systemic Inflammation Deadline: August 1 ahajrnls.org/3Fp2aXx

Incredibly grateful to receive the @American_Heart Student Scholarship in CVD + Howard S. Silverman Scholar distinction! Could not be here without the support of the Natarajan Lab and @CWRUSOM - excited to return to Boston for the summer!

Grateful to @AHAScience @American_Heart for the opp to work w/ an amazing team to launch the PACT-CKM research / training center @MGHHeartHealth @MghObgyn @MGHWomenHeart @mghcvrc @UPMCnews @BrighamWomens @SalemState @odemler @CEPoweMD @malamo512 @mvaduganathan @SamiaMoraMD

Proud to present the 12 Month Follow-Up Results from European Multicenter Heart Transplantation Trial at #ISHLT2025 in Boston with 💪 outcome of hypothermic oxygenated perfusion! A big 🙏 to all collaborators!

Thrilled to be a part of this study led by superstar 🌟@AndreZimerman in @CircAHA 👇! FOURIER analysis, PCSK9i in systemic inflammatory diseases (RA most common AID), and check out @AndreZimerman 🔥thread summarizing key points of the study. @rgiugliano @alkunzler

Growing evidence links clonal hematopoiesis🧬to kidney disease 🫘 Check out a review of recent findings by us @pnatarajanmd @DrFlashHeart on @JASN_News -including our latest collaborative work on same journal—as we unravel this important connection: journals.lww.com/jasn/abstract/…

Our latest on 🫀 health, 🧬, & 🤰 now out in @JACCJournals #JACC ⬆️ 1st-trimester CV health strongly associates w/ ⬇️ risk of hypertensive disorders of 🤰 (HDP) overall & across levels of HDP 🧬 risk ➡️ opp to prevent 🤰 complications & long-term CVD jacc.org/doi/10.1016/j.…

New online! Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target nature.com/articles/s4156…

Thrilled to share our review on clonal hematopoiesis (and CHIP) in cardiovascular diseases! @mchonig and I discuss CHIP's potential role as prognostic factor and therapeutic target in atherosclerotic disease, heart failure and arrhythmias nature.com/articles/s4156… @NatRevCardiol

What could be better? We just published two #TG papers on National Triglycerides Day! Let's start with: Epidemiology and Longitudinal Course of Chylomicronemia: Insights from NHANES and a Large Health Care System in @LipidJournal by @nationallipid sciencedirect.com/science/articl…

Highly recommend for everyone at ACC!! @ourhealthstudy

I'm super excited to share that our work on clonal hematopoiesis in the tumour microenvironment is now published in @CellRepMed!! By tracking CH mutations from the blood into the tumour (CH-Tum), we uncovered some new insights about CH in solid cancer cell.com/cell-reports-m…